• Skip to primary navigation
  • Skip to content
  • Skip to footer navigation
Aucta Pharma

Aucta Pharma

  • About Aucta
  • Strategy
  • Product Portfolio
  • Therapeutic Area
  • Investors
  • Contact Us
  • English
    • 简体中文
  • Strategy
  • Research
  • Commercial
  • Manufacturing

64x64

Aucta is a company creating better products of proven molecules.

Our corporate strategy is to focus on proven molecule, use 505(b)(2) regulatory pathway, through innovation, creating new therapeutics, with lower scientific risk and meet unmet medical needs in attractive market.

Aucta Pharmaceuticals is a new drug product development company focusing on branded 505b2 new product development. Aucta adopts a branded/generic hybrid model, generating both near term product revenue and mid/long term investment return, it aims to become a significant specialty pharma player in the U.S. and China market place. We focus on improved dosage forms for patients with a therapeutic focus in Pediatrics, CNS and Dermatology area.

  • About Aucta
  • Strategy
  • Product Portfolio
  • Therapeutic Area
  • Investors
  • Contact Us
  • English
Powered by Points Group • Privacy Policy •